ArticleInternational journal of molecular sciences2024

Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib.

Yanan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.